EP2836433B1 - Appareil de remplissage modulaire et procédé correspondant - Google Patents

Appareil de remplissage modulaire et procédé correspondant Download PDF

Info

Publication number
EP2836433B1
EP2836433B1 EP13775294.5A EP13775294A EP2836433B1 EP 2836433 B1 EP2836433 B1 EP 2836433B1 EP 13775294 A EP13775294 A EP 13775294A EP 2836433 B1 EP2836433 B1 EP 2836433B1
Authority
EP
European Patent Office
Prior art keywords
filling
station
septum
liquid sealant
conveyor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Not-in-force
Application number
EP13775294.5A
Other languages
German (de)
English (en)
Other versions
EP2836433A4 (fr
EP2836433A1 (fr
Inventor
Daniel Py
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Py Institute LLC
Original Assignee
Dr Py Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Py Institute LLC filed Critical Dr Py Institute LLC
Priority to EP18198318.0A priority Critical patent/EP3456643A1/fr
Publication of EP2836433A1 publication Critical patent/EP2836433A1/fr
Publication of EP2836433A4 publication Critical patent/EP2836433A4/fr
Application granted granted Critical
Publication of EP2836433B1 publication Critical patent/EP2836433B1/fr
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02—Sterilising, e.g. of complete packages
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02—Sterilising, e.g. of complete packages
    • B65B55/025—Packaging in aseptic tunnels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultra-violet radiation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B51/00—Devices for, or methods of, sealing or securing package folds or closures; Devices for gathering or twisting wrappers, or necks of bags
    • B65B51/02—Applying adhesives or sealing liquids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02—Sterilising, e.g. of complete packages
    • B65B55/022—Sterilising, e.g. of complete packages of flexible containers having a filling and dispensing spout, e.g. containers of the "bag-in-box"-type
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02—Sterilising, e.g. of complete packages
    • B65B55/04—Sterilising wrappers or receptacles prior to, or during, packaging
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02—Sterilising, e.g. of complete packages
    • B65B55/04—Sterilising wrappers or receptacles prior to, or during, packaging
    • B65B55/08—Sterilising wrappers or receptacles prior to, or during, packaging by irradiation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02—Sterilising, e.g. of complete packages
    • B65B55/04—Sterilising wrappers or receptacles prior to, or during, packaging
    • B65B55/10—Sterilising wrappers or receptacles prior to, or during, packaging by liquids or gases
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B61/00—Auxiliary devices, not otherwise provided for, for operating on sheets, blanks, webs, binding material, containers or packages
    • B65B61/002—Auxiliary devices, not otherwise provided for, for operating on sheets, blanks, webs, binding material, containers or packages for drying glued or sealed packages
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B65/00—Details peculiar to packaging machines and not otherwise provided for; Arrangements of such details
    • B65B65/003—Packaging lines, e.g. general layout
    • B65B65/006—Multiple parallel packaging lines
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B7/00—Closing containers or receptacles after filling
    • B65B7/16—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B39/00—Nozzles, funnels or guides for introducing articles or materials into containers or wrappers
    • B65B2039/009—Multiple outlets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B2210/00—Specific aspects of the packaging machine
    • B65B2210/02—Plurality of alternative input or output lines or plurality of alternative packaging units on the same packaging line for improving machine flexibility

Definitions

  • the present invention relates to a method comprising the following steps:
  • Apparatuses and methods for aseptic filling invented by the present inventor involve sterilizing a sealed empty device, such as a vial, introducing a needle through a resealable stopper of the vial to sterile fill the interior of the vial with a medicament or other substance, withdrawing the needle from the stopper, and applying laser radiation to the resulting penetration aperture to thermally reseal the penetration aperture and, in turn, hermetically seal the aseptically filled substance within the vial.
  • Exemplary apparatuses and methods are disclosed in the following patents and patent applications : U.S. Patent Application Serial No. 08/424,932, filed April 19, 1995 , entitled "Process for Filling a Sealed Receptacle under Aseptic Conditions," issued as U.S. Patent No.
  • Such apparatuses and methods represent a substantial improvement over prior art filling apparatus and methods, such as those that fill open containers.
  • the apparatuses and methods require a resealable stopper that can absorb the laser radiation, convert it to heat and, in turn, locally melt the stopper at the penetration aperture to reseal it.
  • the sealed empty devices are sterilized prior to needle filling by applying gamma and/or ebeam radiation, or a fluid sterilant, such as vaporized hydrogen peroxide ("VHP”), to at least the penetrable surfaces of the devices to achieve or otherwise ensure a desired sterility assurance level (“SAL”) on the needle penetrable surfaces.
  • VHP vaporized hydrogen peroxide
  • step (iv) further includes applying radiation or energy to the liquid sealant and curing the liquid sealant from a liquid phase to a solid phase substantially at room temperature.
  • Some embodiments further comprise introducing an overpressure of sterile air or other gas over the device during each of steps (ii) through (iii).
  • Some embodiments further comprise introducing an overpressure of sterile air or other gas over the device during each of steps (i) through (iv).
  • Some embodiments further comprise applying a higher pressure of sterile air or other gas during step (ii) as compared to either of steps (i) or (iii) to create a positive pressure gradient between a filling station and de-contamination and curing stations.
  • step (i) includes introducing the device into a de-contamination station and de-contaminating at least the penetrable surface of the septum within the de-contamination station;
  • step (ii) includes moving the de-contaminated device into the filling station including at least one filling needle or filling of injection member coupled in fluid communication with a source of substance to be filled into the chamber of the device, moving at least one of the filling needle and the device relative to the other within the filling station to penetrate the septum with the filling needle, introducing substance through the filling needle and into the chamber, and withdrawing the filling needle from the septum;
  • step (iii) includes moving the filled device from the filling station into a resealing station and applying a liquid sealant onto the penetrated region of the septum within the resealing station;
  • step (iv) includes moving the filled device from the filling station into a curing station and applying radiation or energy to the liquid sealant to cure the liquid sealant from a liquid phase to a solid phase
  • step (i) includes applying UV radiation to at least the penetrable surface of the septum.
  • the UV radiation includes a wavelength or spectrum within the range of about 220 nm to about 300 nm, such as within the range of about 240 nm to about 280 nm, and is applied at a power within the range of about 40 W to about 80 W, such as within the range of about 50 W to about 70 W, for example at about 60 Watts.
  • step (iv) includes applying UV radiation at a wavelength or spectrum within the range of about 200 nm to about 500 nm, such as within the range of about 300 nm to about 400 nm, and at an irradiation intensity within the range of about 1 ⁇ 2 W/cm 2 to about 1-1 ⁇ 2 W/cm 2 , e.g., least 1.0 W/cm 2 .
  • Same embodiments further comprise curing the liquid sealant from a liquid phase to a solid phase within a time period of less than about one minute, which can be less than about 1 ⁇ 2 minute, or even less than about 1 ⁇ 3 minute.
  • step (iv) includes moving a liquid sealant dispenser toward the septum to apply the liquid sealant, and then moving the dispenser away from the septum after applying the liquid sealant or vice versa, e.g. moving the septum.
  • Some such embodiments further comprise breaking any filaments of liquid sealant extending between the septum and dispenser during relative movement of the dispenser and septum to allow such sealant to settle on the septum for curing.
  • the septum is sufficiently elastic to close itself after withdrawal of the injection member or like from the septum and substantially prevent the liquid sealant from flowing through the penetrated region of the septum and into the chamber of the device.
  • the liquid sealant can be sufficiently viscous to also prevent the liquid sealant from flowing through the penetrated region of the septum and into the chamber of the device prior to curing the liquid sealant from the liquid phase to the solid phase.
  • the apparatus comprises a conveyor defining a path for transporting at least one device along the path.
  • Each device includes a penetrable septum and a sealed chamber in fluid communication with the septum.
  • a de-contamination station is located on along conveyor path and is configured to receive the device and to de-contaminate at least the penetrable surface of the septum.
  • a filling station is located along the conveyor path downstream of the de-contamination station and includes at least one filling needle or injection or filling member coupled or coupleable in fluid communication with a source of substance to be filled into the chamber of the device.
  • the filling instrument and/or the device is movable relative to the other within the filling station to penetrate the septum with the filling instrument, introduce substance through the filling instrument and into the chamber, and withdraw the filling instrument from the septum.
  • a resealing station is located along the conveyor path downstream of the filling station and includes at least one liquid sealant dispenser coupled or coupleable in fluid communication with a source of liquid sealant for applying liquid sealant, e.g., a substantially metered amount of sealant, onto the penetrated region of the septum.
  • a curing station is located along the conveyor path downstream of the filling station and includes at least one radiation or energy source for applying energy or radiation to the liquid sealant to cure the liquid sealant from a liquid phase to a solid phase.
  • Embodiments further comprise at least one source of sterile air or other gas coupled in fluid communication with the de-contamination, filling, resealing and curing stations, and configured for introducing an overpressure of sterile air or other gas within each station.
  • the source of sterile air or other gas introduces an overpressure of sterile air or other gas within the filling station at a higher pressure than in the de-contamination and curing stations to create a positive pressure gradient between the filling station and the de-contamination and curing stations.
  • Some embodiments further comprise a frame and one or more modules mounted on the frame.
  • Each module includes a de-contamination station, a filling station, a resealing station and/or a curing station.
  • Each module can further include a respective portion of the conveyor. If desired, each module can include a plurality of stations, and the stations may be the same types of stations or may be different types of stations.
  • a first module includes a plurality of de-contamination stations
  • a second module located downstream of the first module along the conveyor path includes a plurality of filling stations
  • a third module located downstream of the filling module along the conveyor path includes a plurality of resealing stations
  • a fourth module located downstream of the resealing module along the conveyor path includes a plurality of curing stations.
  • Some such embodiments further comprise at least two curing stations for each resealing station to increase throughput and/or decrease cycle time i.e., to achieve desired cycle times as discussed above.
  • each module includes a canopy movable between an open position and a closed position, and defining an enclosure within the module in the closed position.
  • a fan and a filter can be coupled in fluid communication with the fan for pumping air or other gas through the filter to sterilize the air or other gas and introduce the sterile air or other gas into the enclosure.
  • a conveyor module transports devices along the conveyor path within the respective module.
  • An exhaust assembly can be coupled in fluid communication between the enclosure and ambient atmosphere to exhaust the overpressure of sterile air or other gas therethrough.
  • An inlet can be defined at one end of the conveyor module, and an outlet can be defined at another end of the conveyor module.
  • the canopy is mounted over the conveyor module and the exhaust assembly is mounted below the conveyor module.
  • the conveyor module can define a plurality of exhaust apertures in fluid communication between the enclosure and exhaust assembly for the flow of sterile air or other gas therethrough and into the exhaust assembly.
  • the frame includes first and second axially-elongated supports laterally spaced relative to each other, and the exhaust assembly (where present) of each of a plurality of modules is mounted to the first and second supports with the respective conveyor module located therebetween.
  • each conveyor module includes a magnetic rail, and the conveyor includes at least one carriage magnetically coupled to and drivable along the magnetic rail.
  • the magnetic rails of a plurality of conveyor modules can define a substantially continuous conveyor path.
  • the exhaust assembly includes a lower exhaust assembly and an upper exhaust assembly located on an opposite side of the first and second supports relative to the lower exhaust assembly and coupled thereto.
  • the lower and/or upper exhaust assemblies include a conveyor rail mounted between the first and second supports and defining flow apertures therebetween.
  • a plurality of exhaust ports can be coupled in fluid communication between the flow apertures and ambient atmosphere for exhausting sterile air or other gas therethrough and out of the enclosure.
  • each of a plurality of modules includes first and second upstanding supports mounted on opposite sides of the conveyor rail relative to each other.
  • the upstanding supports are configured for supporting a needle, injection member, or filling member, a liquid sealant dispenser and/or a radiation or energy source.
  • the first and second upstanding supports support a needle and/or a liquid sealant dispenser, and are movable toward and away from the conveyor.
  • the first and second supports support (i) a radiation or energy source for de-contaminating devices and/or (ii) a radiation or energy source for curing liquid sealant from a liquid phase to a solid phase.
  • Some embodiments further comprise a first sterile connector and a first fluid conduit coupled between the first sterile connector and the needle, and a second sterile connector and a second fluid conduit coupled between the second sterile connector and a source of substance to be filled.
  • the first sterile connector is connectable to the second sterile connector to form a sealed sterile fluid connection therebetween.
  • Such apparatus may further comprise a third sterile connector and third fluid conduit coupled between the third sterile connector and the liquid sealant dispenser, or a fourth sterile connector and a fourth fluid conduit coupled between the fourth sterile connector and a source of liquid sealant.
  • the third sterile connector is connectable to the fourth sterile connector to form a sealed sterile fluid connection therebetween.
  • the filling station includes a mount including a plurality of filling needles, injection members or filling members laterally spaced relative to each other and fixedly mounted thereon and a plurality of caps.
  • Each cap is releasably connected to the mount in a position covering a respective needle or other filling/injection instrument.
  • the mount is movable toward and away from the conveyor.
  • the conveyor includes a cap fixture including a plurality of cap support surfaces engageable with respective caps when the mount is moved toward the conveyor to releasably retain the caps thereon, and disengage the caps from the mount when the mount is moved away from the conveyor to expose the needles, etc. and ready them for use.
  • an apparatus comprises a conveyor defining a path for transporting one or more devices along the path and one or more modules.
  • Each module includes (i) a de-contamination station located along the conveyor path and configured to receive therein the device and de-contaminate at least a surface of the device; (ii) a filling station located along the conveyor path downstream of the de-contamination station and including at least one filling member or the like coupled or coupleable in fluid communication with a source of substance to be filled into the chamber of the device; and/or (iii) a sealing station located along the conveyor path downstream of the filling station for sealing the filled device.
  • modules having a plurality of the modules, they are located (a) in series with each other, and/or (b) in parallel with each other.
  • the modules can be configured to add additional modules in series or in parallel with such modules to increase throughput or decrease cycle time, and/or to remove one or more of the modules from the conveyor path to decrease throughput or increase the cycle time.
  • each device includes a penetrable septum as other penetrable portion and a sealed chamber in fluid communication therewith.
  • Each of the modules includes (i) a de-contamination station located along the conveyor path and configured to receive therein the device and de-contaminate at least the penetrable surface of the penetrable septum; and (ii) a filling station located along the conveyor path downstream of the de-contamination station and including at least one filling member or like coupleable in fluid communication with a source of substance to be filled into the chamber of the device.
  • the filling needle and/or the device is movable relative to the other within the filling station to penetrate the penetrable portion with the filling needle, introduce substance through the filling needle and into the chamber, and withdraw the filling needle from the septum.
  • a resealing station is located along the conveyor path downstream of the filling station and includes at least one liquid sealant dispenser coupleable or coupled in fluid communication with a source of liquid sealant for applying the liquid sealant onto the penetrated region of the septum.
  • a curing station is located along the conveyor path downstream of the filling station and includes at least one radiation or energy source for applying radiation or energy to the liquid sealant to cure the liquid sealant from a liquid phase to a solid phase.
  • Some embodiments further comprise one or more frames.
  • the modules are mounted on the frame(s).
  • Each module includes a canopy movable between an open position and a closed position, and each canopy defines an enclosure within the module in the closed position.
  • a fan is coupled in fluid communication with each enclosure, and a filter is coupled in fluid communication with each fan for pumping air or other gas through the filter to sterilize the air or other gas and introduce the sterile air or other gas into the respective enclosure.
  • a conveyor module transports devices along the conveyor path within each respective module.
  • An exhaust assembly can be coupled in fluid communication between each respective enclosure and ambient atmosphere to exhaust the overpressure of sterile air or other gas therethrough.
  • a module inlet can be defined at one end of each conveyor module, and a module outlet can be defined at another end of each conveyor module.
  • each module defines an inlet at one end of the respective conveyor module, and an outlet at the opposite end of the respective conveyor module.
  • Each of a plurality of outlets defines the inlet of an adjacent module.
  • each conveyor module includes a magnetic rail, the magnetic rails of the modules define the conveyor path, and the conveyor includes at least one carriage magnetically coupled to and drivable along the magnetic rails of the modules.
  • the radiation or energy curing of the liquid sealant substantially decreases cycle time in comparison to apparatus and methods without such curing, and therefore increases the throughput of such apparatus and methods.
  • the modular construction of the apparatus allows modules to be added to the apparatus to increase throughput and/or to decrease cycle time.
  • the apparatus can include more of the relatively time-consuming (or higher cycle time) stations in comparison to the relatively less time-consuming (or lower cycle time) stations in order to decrease overall cycle time and increase throughput.
  • the apparatus and method includes more curing stations in comparison to resealing stations where the curing requires more time than application of the liquid sealant.
  • additional modules can be added in series and/or in parallel to the other modules to enhance flexibility with respect to the footprint of the apparatus.
  • an aseptic or sterile filling apparatus is indicated generally by the reference numeral 10.
  • the aseptic or sterile filling apparatus 10 is used to fill devices 12, such as containers or delivery devices for storing and dispensing liquid products, such as beverages, food, or nutritional products, vials or syringes for containing and/or dispensing any of numerous different types of products or substances, such as medicaments, vaccines, pharmaceuticals, dermatological products, ophthalmic products, and nutritional supplements, devices for storing and dispensing cosmetic or cosmeceutical products, or devices for storing and dispensing industrial products.
  • devices 12 such as containers or delivery devices for storing and dispensing liquid products, such as beverages, food, or nutritional products, vials or syringes for containing and/or dispensing any of numerous different types of products or substances, such as medicaments, vaccines, pharmaceuticals, dermatological products, ophthalmic products, and nutritional supplements, devices for storing and dispensing cosmetic or cosmeceutical products, or devices for
  • the aseptic or sterile filling apparatus 10 may be used for filling any of numerous different types of devices that are currently known or that later become known, including devices having penetrable or portions or septums and/or sealed chambers in fluid communication therewith, with any of numerous different types of substances that are currently known or that later become known.
  • the aseptic or sterile filling apparatus 10 includes a series of workstations for performing respective functions on a device(s) 12 within the aseptic or sterile filling apparatus 10. It will be understood that the aseptic or sterile filling apparatus 10 may include one or more workstations discussed below or any suitable combination thereof. In certain applications, the aseptic or sterile filling apparatus 10 is capable of bypassing one or more workstations. Additionally, one or more workstations can be substituted for others based on the desired application.
  • the aseptic or sterile filling apparatus 10 includes a frame 18, having first and second axially-elongated supports 20 laterally spaced apart, for supporting a plurality of modules 22 mounted in series thereon. As shown in FIGS. 3 and 4 , each module 22 defines an inlet 24 at one end of the module, and an outlet 26 at the opposite end of the respective module, where the outlet of one module defines the inlet of an adjacent module. At least one workstation is enclosed within each module, each workstation having an operational element configured for a specific operation, as described further below.
  • the apparatus 10 also includes a conveyor 28, comprised of a plurality of conveyor modules 30, as described further below, and forming an axially-elongated and substantially continuous conveyor path between the first and second axially-elongated supports 20.
  • the conveyor 28 includes a loading station 29, defining an inlet to the conveyor, and a discharge station 31, defining an outlet to the conveyor.
  • the conveyor 28 includes a working conveyor 33, a return conveyor 35, and two end conveyors 37.
  • the working conveyor 33 transports carriages 32 along the conveyor path from the loading station 29, through the modules 22, to the discharge station 31.
  • the return conveyor 35 extends between the discharge station 31 to the inlet station 29 and transports carriages 32 in an opposite direction from the working conveyor direction.
  • the return conveyor 29 does not pass through any modules 22. However, in the embodiments they may.
  • the end conveyors 37 are moveable laterally between the working conveyor 33 and the return conveyor 35 to transport carriages 32 therebetween.
  • a carriage 32 may be configured to hold a single device 12 or a plurality of devices, where the plurality of devices may be the same or different types of devices.
  • the first and second axially-elongated supports 20 of the frame 18 define first and second carriage tracks 34, respectively, wherein a carriage 32 slidably engages the carriage tracks.
  • a carriage 32 may engage the carriage tracks 34 via, for example, bearings or rollers.
  • Each carriage 32 includes a device fixture 36 extending from a base thereof, having a plurality of device support surfaces 38 engageable with respective devices 12 to support a device 12 in the fixture 36 and prevent movement of the devices 12 relative to the fixture 36 during transport.
  • the aseptic or sterile filling apparatus 10 further (optionally) includes a source of sterile air or other gas, to introduce an overpressure of sterile air or other gas into each of the modules 22.
  • a source of sterile air or other gas to introduce an overpressure of sterile air or other gas into each of the modules 22.
  • Each module includes a upper assembly 39 mounted on one side of axially-elongated supports 20 of the frame 18 and an (optional) exhaust assembly 42 mounted on an opposite side of the axially-elongated supports relative to the upper assembly 39.
  • the upper assembly 39 is mounted on the upper side of the supports 20 and the exhaust assembly 42 is mounted on the lower side of the supports 20.
  • a bottom surface of the upper assembly 39, lying on the axially-elongated supports 20, is a conveyor module 30. Brackets 48 of the exhaust assembly 42 attach to the conveyor module 30 of the upper assembly 39, thereby attaching the upper assembly 39 to the exhaust assembly 42.
  • each module also includes a canopy 40 covering the upper assembly 39 and moveable between open and closed positions.
  • An enclosure is defined within a module 22 when the canopy 40 is in the closed position.
  • each module 22 also includes at least one fan 44 and a filter 46 coupled in fluid communication with the fan 44 for pumping air or another gas from the source of air and through the filter 46 to introduce an overpressure of sterilized air or other gas into the enclosure.
  • each fan 44 and filter 46 for a respective module 22 are located atop the canopy 40 of the module, in order to introduce an overpressure of air.
  • any of numerous filters that are currently known, or that later become known may be utilized, such as, for example, a high efficiency particulate air (HEPA) filter.
  • HEPA high efficiency particulate air
  • the exhaust assembly 42 includes a conveyor rail 50 extending along the conveyor path and located between the first and second axially-elongated supports 20.
  • a plurality of exhaust flow apertures 52 are defined by spaces between the conveyor rail 50 and the first and second axially-elongated supports 20.
  • the exhaust flow apertures 52 allow the flow of the sterile air or other gas therethrough and out of the enclosure.
  • the exhaust apertures may be axially-elongated and located on opposite sides of the conveyor rail 50 relative to each other.
  • the exhaust assembly 42 also includes at least one exhaust port 54 mounted below the conveyor rail 50 and the apertures 52, and coupled in fluid communication therewith at one end and in fluid communication with an exhaust manifold 56 at the other end.
  • the exhaust manifold 56 vents the sterile air or gas out to the ambient atmosphere.
  • the sterile air or gas is vented out of an enclosure through the exhaust flow apertures 52, the exhaust port 54 and the exhaust manifold 56 and into the ambient atmosphere.
  • the conveyor rail 50 is a magnetic rail to provide quick and efficient transport of the devices 12 between workstations, as well as precise positioning thereof in proper alignment with a workstation.
  • the carriages 32 are magnetically coupled and drivable along the magnetic rail.
  • the carriages 32 are transported along the magnetic rail via a motor, such as, for example, a linear synchronous motor, node controllers for controlling the carriages, and a control unit 58 to control the speed and position of an individual carriage.
  • a motor such as, for example, a linear synchronous motor, node controllers for controlling the carriages, and a control unit 58 to control the speed and position of an individual carriage.
  • the conveyor 28 may be configured, using the control unit 58, to allow only certain carriages 32 to progress through a select number of stations and bypass other stations.
  • other types of conveyor systems may be used that are known or become known.
  • a belt conveyor may be used.
  • the carriages 32 may be moved by other mechanisms, such as cable, belt, or direct drive motor using a friction drive or gear/rack type system.
  • each module 22 also includes first and second upstanding supports 60 mounted on opposite sides of the conveyor rail 50 to the conveyor module 30 for supporting at least one operational element of the respective workstation(s) located within the module. It will be noted that in FIGS. 4-6 , the canopy of at least one module is in the open position to facilitate viewing the interior of the module.
  • the aseptic or sterile filling apparatus 10 includes a de-contamination station 62, a filling station 64, a resealing station 66 and a curing station 68 as seen in FIG. 1 .
  • the workstations are located along the conveyor path in this sequence so that the carriage 32 and devices 12 thereon pass through the workstations in this order.
  • the de-contamination station 62 is the first station located on the conveyor path after the loading station 29.
  • the de-contamination station 62 decontaminates at least the penetrable surface of the penetrable portion septum 14 via an energy or radiation source 70.
  • the apparatus 10 further includes a filling station 64 located downstream of the de-contamination station 62.
  • the needle filling station 64 includes a plurality of filling needles 72 or like injection or filling instruments that can be in fluid communication with a source of substance to be filled into the chamber 16 of a device 12.
  • the apparatus 10 further includes a resealing station 66 located downstream of the filling station 64.
  • the resealing station 66 includes one or more liquid sealant dispensers 74 placeable in fluid communication with a source of liquid sealant for applying a liquid sealant onto the penetrated region of a device septum 14.
  • the liquid sealant can be applied in a substantially metered amount for consistency.
  • the apparatus 10 further includes a curing station 68 located downstream of the resealing station 66.
  • the curing station 68 includes at least one energy or radiation source 75 connected to a radiation or energy generating or emitting unit 76 for applying radiation or energy to the liquid sealant to cure the liquid sealant from a liquid phase to a solid phase.
  • an overpressure of sterile air or gas can be introduced into each of the workstations.
  • the sterile air or gas is introduced into the filling station 64 at a higher pressure than in the de-contamination 62 and curing stations 68 to create a positive pressure gradient between the filling station and the de-contamination and curing stations.
  • the workstations are hereinafter described in further detail.
  • the de-contamination station 62 is the first workstation in the sequence.
  • the de-contamination station includes one or more energy or radiation sources 70 supported by the first and second upstanding supports 60 for sterilizing or at least de-contaminating a septum 14 of a device 12 prior to filling.
  • the de-contamination station can be configured to decontaminate more than the penetrable portion 14 of the device 12.
  • Suitable energy or radiation sources include gamma radiation, UV radiation and e-beam or beta radiation. Gamma radiation penetrates matter deeply and can be used to irradiate the inside and outside of the device 12. UV radiation can also be used in sterilizing the device 12 prior to filling. UV provides several advantages such as ease of use, low cost of installation and use and minimal damage to substrate materials. UV sterilization may be accomplished through either continuous wave UV sterilization or pulsed UV sterilization.
  • pulsed UV light allows for quick and effective sterilization of the device 12 as it moves from one workstation to the next.
  • the pulsed UV light can be provided by way of two four-channel de-contamination substations having Xenon flash lamps.
  • Pulsed UV sterilization of a portion of the device 12 is accomplished using a pulse generator connected to a Xenon flash lamp.
  • the pulse generator is utilized to trigger the required number of pulses per second for the Xenon flash lamps for successful sterilization of the device septum 14.
  • a 10 MHz pulse generator can be utilized to trigger the Xenon flash lamps greater than 470 times per second.
  • a 2.0 MHz amplifier can be utilized to increase the trigger signal power distributed to the two four-channel substations.
  • the Xenon flash lamps function at a wavelength or spectrum, for example, within the range of about 240 nm and about 280 nm, or within the range of about 254 nm and about 260 nm.
  • the lamps are operated within the range of about 400 VDC to about 1000 VDC, e.g., at about 800 VDC, at about 60 Watt power. It has been found that operation within the range of about 3 seconds and about 10 seconds is suitable, and in a number of applications, for a period of about 5 seconds at each de-contamination substation.
  • the devices 12 are de-contaminated for about 5 seconds under each of the two de-contamination substations for a total of about 10 seconds.
  • a sterility assurance level (SAL) of at least about log 3 can thus be achieved for the device septums.
  • SAL sterility assurance level
  • a fan or plurality of fans may be introduced to eliminate ozone and heat.
  • a single fan with a single sterile filter is used.
  • two or three fans are used to control flow, with the outlet of each fan being coupled to a sterile filter.
  • the aseptic or sterile filling apparatus 10 further includes a needle filling station 64 as the second workstation in the sequence after the de-contamination station 62.
  • the needle filling station 64 is located in a different module than the de-contamination station 62. Alternatively, it may be located in the same module or another location. After the septums 14 of the devices 12 have been sterilized in the de-contamination station 62, the devices are transported downstream from the de-contamination station 62 to the filling station 64. As shown in FIG.
  • the filling station 64 includes a plurality of filling needles 72 or other injections or filling members laterally spaced relative to each other and fixedly mounted to a mount 78 that is supported by the first and second upstanding supports 60.
  • any of numerous filling needles or filling members that are currently known, or that later become known may be utilized to fill a substance into the device.
  • a self opening and closing filling device may also be utilized to sterile fill the device(s) 12 in accordance with the teachings of U.S. Patent Application Serial No.
  • a single lumen non-coring needle may be utilized to dispense a substance into a device when there is no need to provide a venting channel for positive pressure within the device.
  • a double lumen non-coring needle may be utilized to dispense a substance into a device through the eye of the needle and also provide a venting channel between the inner and outer lumens to vent out to the atmosphere any positive pressure in the device at the inception of filling as well as pressure developed within the container during filling.
  • the needle filling station 64 also includes drive shafts 80 rotatably mounted between opposite sides of the exhaust assembly brackets 48 below the conveyor module 30, and having a drive motor 82 connected thereto.
  • the first and second upstanding supports 60 in these stations extend through the conveyor module 30 and drivingly connect to the ends 84 of the drive shafts 80.
  • Drive motors 82 rotatably drive the drive shafts 80 to move the first and second upstanding supports 60 toward and away from the devices 12.
  • any of numerous motors currently known, or that later become known such as, for example, a Z axis servo motor, may be utilized to rotate the drive shafts and drive the upstanding supports toward and away from the devices.
  • the drive shaft 80 lowers the first and second upstanding supports 60, and thus the mount 78 holding the filling needles 72 toward the carriage 32, the filling needles 72 penetrate the penetrable septums 14 of the respective aligned devices 12, introduce a substantially metered amount of a substance therethrough and into the chambers 16 of the respective devices 12, and then the drive shaft 80 raises the mount 78 away from the devices 12 to withdraw the filling needles 72 therefrom.
  • the drive motor 82 may be programed to lower the filling needles 72 to an operator-specified stroke to ensure that the filling needles 72 are automatically lowered to the correct depth required for the tips of the filling needle to fully penetrate the penetrable portion or septum 14 of a respective device 12 and enter the device chamber 16.
  • the specified stroke depends upon the device 12, e.g., its height in the carriage 32.
  • the filling needles 72 are raised, e.g., automatically back to their original location, ensuring that the filling needle tips have exited and cleared the respective device(s) 12.
  • the filling station 64 also includes a pump 86, such as, for example, a peristaltic pump, connected between a source of substance and the filling needles 72 to ensure that the correct volume of substance is delivered to each device 12.
  • a pump 86 such as, for example, a peristaltic pump
  • any of numerous pumps or metering devices currently known, or that later become known, may be utilized to ensure a correct amount of substance is delivered to each device.
  • the filling station 64 also includes a valve, such as, for example, a pinch valve, connected between the source of substance and the filling needles 72 to isolate the substance from the eye of the needle for a drip-free environment as well as to isolate residual substance in the substance line when the dispensing of substance is complete.
  • a valve such as, for example, a pinch valve
  • any of numerous valves currently known, or that later become known, may be utilized to ensure that substance does not drip from the eye of a filling needle.
  • a plurality of caps 88 are disposed on the filling needles 72.
  • Each cap 88 is releasably connected to the mount 78 in a position covering a respective filling needle 72.
  • the conveyor 28 includes a cap fixture 90 having a plurality of cap support surfaces 92 engageable with respective caps 88.
  • the mount 78 Prior to the passing of a carriage 32 carrying a set of devices 12, the mount 78 is moved toward the cap fixture 90 to releasably retain the caps 88 on the cap support surface 92, and disengage the caps 88 from the mount 78 when the mount is moved away from the cap fixture 90. This exposes the filling needles 72 and readies them for use.
  • caps 88 protect the filling needles 72 and maintain the sterility of said needles when the needles are not in use.
  • the caps may be configured to removably cover and/or protect other types of filling instruments in embodiments where such are used.
  • each filling needle 72 can be connected in fluid communication to a substance source by one or more filling lines 94 for receiving therefrom a substance to be filled into the devices 12.
  • each filling line 94 includes a first fluid conduit 91 and a second fluid conduit 93, as shown in FIGS. 14 and 15 .
  • the first fluid conduit 91 is coupled to a filling needle 72 at one end and to a first sterile connector 95 at the other end.
  • the second fluid conduit 93 is coupled to the substance source at one end and to a second sterile connector 97 at the other end.
  • the first sterile connector 95 and the second sterile connector 97 are connectable to form a sealed sterile fluid connection therebetween, and thus connect the filling needle 72 in fluid communication with substance source.
  • any suitable sterile connector may be used to connect the substance source to the filling needles 72.
  • the first sterile connector 95 and the second sterile connector 97 are the first and second ports of a sterile DROC-type connector 96.
  • the DROC-type connector 96 is described in U.S. Patent Application Serial No. 13/080,537, filed April 5, 2011 , entitled “Aseptic Connector With Deflectable Ring of Concern and Method," which, in turn, claims the benefit of similarly titled U.S. Provisional Patent Application Serial No. 61/320,857, filed April 5, 2010 .
  • the substance source can be mounted external to the filling station 64, and the filling line(s) 94 connected between the substance source and the filling needles 72 are protected by suitable shielding, an electron trap, and/or other arrangement that is currently known, or later becomes known to those of ordinary skill in the pertinent art, to prevent radiation or energy from the sterilization station from degrading or otherwise damaging the substance flowing through the line(s) 94 from the substance source to the filling needles 72.
  • the devices 12 After the devices 12 have been filled with, e.g., a substantially metered amount of, substance, the devices are transported downstream from the filling station 64 to one or more resealing stations 66 as shown in FIG. 12a .
  • the resealing station 66 is located within the same module 22 as the filling station 64.
  • the resealing station 66 may equally be located in a separate module or another location.
  • resealing of the container is accomplished, at least in part, through the use of a liquid sealant in the same or substantially similar manner as that disclosed in U.S. Patent Application Serial No.
  • the resealing station 66 may be introduced immediately after the filling station 64 or elsewhere. In some embodiments, the device 12 arrives at the resealing station 66 after being pierced and filled with a substance using a non-coring filling needle at a filling station 64.
  • a plurality of liquid sealant dispensers 74 are supported by the first and second upstanding supports 60, which are moveable toward and away from a carriage 32 via a drive shaft 80 and drive motor 82 in the same manner as previously described with respect to the filling station 64.
  • the liquid sealant dispensers 74 are lowered to the appropriate level to dispense a liquid sealant to seal the septums 14 of the respective aligned devices 12.
  • the liquid sealant dispensers 74 dispense a substantially metered amount of sealant onto the penetrated septum 14 to fully cover the septum.
  • the sealant dispensers 74 are raised away from the carriage 32 and back to their original location. Movement of the liquid sealant dispensers 74 toward the devices 12 is helpful to evenly apply liquid sealant to a septum 14, especially when the liquid sealant includes a material having a high viscosity. Movement of the liquid sealant dispensers 74 away from the devices 12 breaks any filaments of the liquid sealant extending between a septum 14 and a liquid sealant dispenser 74 to allow the sealant to settle on the septum 14. Alternatively, the devices 12 may be moved relative to the dispenser 74.
  • the liquid sealant dispenser can be formed of any member, currently known, or that later becomes known, capable of dispensing a predetermined amount of sealant onto a target region, such as, for example, a suitable tube, a dropper, or pipette.
  • the liquid is heated.
  • a heated sealant provides desired flow and/or viscosity characteristics.
  • the liquid sealant is a silicone, such as, for example, a medical grade liquid silicone.
  • the liquid sealant can take the form of any of numerous different sealants that are currently known, or that later become known.
  • the sealant may be sufficiently viscous to prevent the liquid sealant from flowing through the penetrated region of a septum 14 and into the chamber 16 of a device 12 prior to curing the liquid sealant from the liquid phase to the solid phase.
  • the septum 14 can be configured to be sufficiently elastic to close upon itself after withdrawal of a filling needle 72 therefrom to substantially prevent the liquid sealant from flowing through the penetrated region of the septum 14 and into the chamber 16 of the device 12.
  • the resealing station 66 also includes a source of liquid sealant, or is connectable in fluid communication with a source of liquid sealant, such as, for example, a pressurized reservoir, and a pump 86, such as but not limited to the pump described in connection with the needle filling station 72, for pumping liquid sealant, e.g., metered amounts onto the penetrated septums 14 of the devices 12.
  • a source of liquid sealant such as, for example, a pressurized reservoir
  • a pump 86 such as but not limited to the pump described in connection with the needle filling station 72, for pumping liquid sealant, e.g., metered amounts onto the penetrated septums 14 of the devices 12.
  • the pump may take the form of any of numerous other mechanisms for pumping or metering volumes or other measured amounts of liquid sealant for delivery onto the penetration portions of the devices, that are currently known, or that later become known, such as, for example, a piston pump, or other systems with pressurized liquid sealant and valves for releasing the pressurized sealant.
  • a valve such as a specialty diaphragm valve may be connected in fluid communication between the liquid sealant source and the liquid sealant dispensers to control the weight and volume of the liquid sealant drops. The volume of the drops may be adjusted by an operator.
  • the valves may also hold back the liquid sealant from the tips of the liquid sealant dispensers via a suck back feature to ensure a drip free environment.
  • any suitable sterile connectors may be used to connect the liquid sealant source, the filling line(s) 94 and the liquid sealant dispensers 74.
  • the filling line(s) 94 may include a first fluid conduit 91 and a second fluid conduit 93, as shown in FIGS. 14 and 15 .
  • the first fluid conduit 91 is coupled to a liquid sealant dispenser at one end and to a first sterile connector 95 at the other end.
  • the second fluid conduit 93 is coupled to the liquid sealant source at one end and to a second sterile connector 97 at the other end.
  • the first sterile connector 95 and the second sterile connector 97 are connectable to form a sealed sterile fluid connection therebetween, and thus connecting the liquid sealant dispenser 74 in fluid communication with the liquid sealant source.
  • Any one or a combination of the liquid sealant source, the filling line(s) 94 and the liquid sealant dispenser 74 may utilize a sterile DROC-type connector 96 or any of the sterile/aseptic connectors mentionned above.
  • the liquid sealant source can be mounted external to the resealing station 66 or within it, and the filling line(s) 94 connected between the substance source and the liquid sealant dispensers 74 can be protected by suitable shielding, an electron trap, and/or other arrangement that is currently known, or later becomes known to those of ordinary skill in the pertinent art, to prevent radiation from prematurely curing the liquid sealant prior to dispensing on a septum 14 of a device 12.
  • the devices 12 are transported downstream to a curing station 68, wherein the sealant is exposed to a source of energy or radiation 75 to cure the liquid sealant.
  • a curing station 68 may be disposed after the resealing station 66.
  • Exposure of the liquid sealant to a suitable radiation or energy source will cure, e.g., accelerate, the liquid sealant from a liquid phase to a solid phase, thereby sealing the pierced septum 14 of the device 12 and hermetically sealing the filled substance within device from the ambient atmosphere.
  • Radiation or energy curing of a liquid sealant provides several advantages over room temperature curing, such as ease of use, process consistency and significantly decreasing curing time, thus greatly increasing curing efficiency and device throughput.
  • Selection of a radiation or energy source is based upon the photoinitiator in the liquid sealant, which initiates curing of the sealant. Successful photoinitiator activation requires exposure to radiation or energy at a suitable wavelength or spectrum at sufficient intensity for a sufficient time. Therefore, the radiation or energy source should be selected to match the photoinitiator characteristics of the sealant. Alternatively, the sealant can be selected so that its photoinitiation characteristics compliment the radiation or energy source to be used.
  • a liquid silicone sealant is dispensed in the resealing station 66.
  • a UV wavelength within the range of about 300 nm to about 400 nm, such as a wavelength of approximately 365 nm, at an irradiation intensity greater than about 1 W/cm 2 , such as greater than about 1.5 W/cm 2 , is sufficient to activate the photoinitiator therein and successfully cure the sealant within an acceptable timeframe.
  • the radiation or energy source 75 is a UV source, and the emitting unit 76 emits UV radiation.
  • curing of the liquid silicone from a liquid phase to a solid phase can be accomplished within a time period of less than about 30 seconds.
  • the sealant, and radiation wavelength, intensity, and/or the sealant can be selected to accomplish curing in less than about 20 seconds.
  • curing of the liquid silicone is accomplished by a two-stage process provided by way of two four-channel curing substations.
  • the first curing substation utilizes a Light Emitting Diode (LED) driver delivering radiation to four 10 W collimator head units that amplify and emit the radiation onto the sealant.
  • the second curing substation utilizes 200 W Xenon spot curing lamps delivering radiation to light guides that amplify and emit the radiation.
  • both the LED collimator head units and the Xenon spot curing lamps provide a UV wavelength within the range of about 300 nm to about 400 nm, e.g., about 365 nm, to cure the liquid silicone.
  • the sealant is cured for about 5 seconds under each of the two curing substations for a total of about 10 seconds.
  • either the LED drivers/collimator head units combination or the Xenon spot curing lamps/light guides combination is utilized in both of the curing substations.
  • a suitable liquid silicone sealant for sealing the resealable portion is LOCTITE #5056 sealant, which photoinitiates at about 365 nm.
  • Other suitable UV curable sealants are available from DYMAX, which photoinitiates at about 395 nm. Further sealants utilize 254 nm light. It should be noted, then, that UV curable sealants other than liquid silicone can be used, for example, acrylic-based UV curable sealants.
  • liquid sealant other than those that are UV curable can be used to hermetically seal the penetrated septum, such as visible light (e.g., 400-436 nm) or infrared curable products, as are known or subsequently may become known.
  • the radiation or energy source is selected to generate an energy discharge or wavelength spectrum at sufficient intensity to cure the sealant within a desired time and based on process parameters and production requirements.
  • the aseptic or sterile filling apparatus 10 may include other workstations in addition to or in substitution of the workstations described herein.
  • the interior chamber of a device may be sterilized in a sterilization station, such as by injecting a fluid sterilant therein, such as nitric oxide, in accordance with the teachings of U.S. Provisional Patent Application Serial No. 61/499,626, filed June 21, 2011 , entitled "Nitric Oxide Injection Sterilization Device and Method".
  • each workstation may include alterative operational elements, which may be mounted in any of numerous different ways that are currently known, or that later become known, for performing the functions of the operational elements as described herein.
  • an electron beam source may be utilized in lieu of a UV source to decontaminate a device septum.
  • access to repair and/or replace a damaged operational element may be obtained via opening of the canopy.
  • the spacing between the operational elements in the workstations may also be adjusted depending on the carriages used and the number of devices on each carriage. Accordingly, this detailed description of currently preferred embodiments is to be taken in an illustrative, as opposed to a limiting sense.

Claims (18)

  1. Un procédé comprenant les étapes suivantes consistant à :
    (i) décontaminer au moins une surface pénétrable d'un dispositif (12) comprenant une part ou septum (14) pénétrable par aiguille pénétrable par un élément de remplissage ou d'injection (72) et une chambre hermétique (16) en communication fluidique avec le septum pénétrable (14) ;
    (ii) déplacer un élément de remplissage ou d'injection (72) et / ou le dispositif (12) relative à l'autre afin de pénétrer le septum pénétrable (14) avec l'élément de remplissage ou d'injection (72), introduire de la substance à travers l'élément de remplissage ou d'injection (72) et dans la chambre (16), et retirer l'élément de remplissage ou d'injection (72) du septum (14) ;
    (iii) chauffer un produit d'étanchéité liquide et l'application du produit d'étanchéité liquide chauffé sur la région pénétrée du septum (14) ; et
    (iv) fermer hermétiquement la région pénétrée du septum (14).
  2. Un procédé selon la revendication 1, dans lequel l'étape (iv) comprend en outre l'application de rayonnement ou d'énergie au produit d'étanchéité liquide et le durcissement du produit d'étanchéité liquide d'une phase liquide à une phase solide, de préférence sensiblement soit à peu près à la température ambiante ou à la température de la pièce.
  3. Un procédé selon la revendications 1 ou 2, comprenant en outre l'introduction d'une surpression d'air stérile ou d'un autre gaz sur le dispositif (12) pendant chacune des étapes (ii) à (iii), de préférence l'application d'une pression plus élevée d'air stérile ou d'un autre gaz pendant l'étape (ii) par rapport à l'une ou l'autre des étapes (i) ou (iii).
  4. Un procédé selon l'une des revendications 2 à 3, dans lequel l'étape (i) comprend l'introduction du dispositif (12) dans une station de décontamination (62) et la décontamination au moins de la surface pénétrable du septum (14) pénétrable à l'intérieur de la station de décontamination (62) ;
    l'étape (ii) comprend le déplacement du dispositif (12) décontaminé dans une station de remplissage (64) comprenant au moins un élément de remplissage ou d'injection (72) couplé en communication fluidique avec une source de substance à remplir dans la chambre (16) du dispositif (12), le déplacement de l'élément de remplissage ou d'injection (72) et / ou du dispositif (12) en relation de l'autre au sein du station de remplissage (64) afin de pénétrer le septum pénétrable (14) avec l'élément de remplissage ou d'injection (72), l'introduction de substance à travers l'élément de remplissage ou d'injection (72) et dans la chambre (16), et le retrait de l'élément de remplissage ou d'injection (72) du septum (14) ;
    l'étape (iii) comprend le déplacement du dispositif (12) rempli de la station de remplissage (64) dans une station (66) de rescellage et l'application d'un produit d'étanchéité liquide sur la région pénétrée du septum (14) à l'intérieur de la station de rescellage (66) ; et
    l'étape (iv) comprend le déplacement du dispositif (12) rempli de la station de rescellage (66) vers une station (68) de durcissement et l'application de rayonnement ou de l'énergie au produit d'étanchéité liquide afin de durcir le produit d'étanchéité liquide d'une phase liquide à une phase solide dans la station de durcissement (68).
  5. Un procédé selon la revendication 4, comprenant en outre l'introduction d'une surpression d'air stérile ou d'autre gaz à l'intérieur de chacune des stations de décontamination, de remplissage, de rescellage et de séchage (62, 64, 66, 68) de préférence l'introduction une surpression d'air stérile ou d'autre gaz à l'intérieur de la station de remplissage (64) à une pression plus élevée que dans les stations de décontamination et de durcissement (62, 68) afin de créer un gradient de pression positif entre la station de remplissage (64) et les stations de décontamination et de durcissement (62, 68).
  6. Un procédé selon l'une des revendications 1 to 5, dans lequel l'étape (i) comprend l'obtention d'un niveau d'assurance de stérilité ou SAL sur la surface pénétrable du septum (14) d'au moins environ log 3.
  7. Un procédé selon l'une des revendications 1 to 6, dans lequel l'étape (iv) comprend l'application d'un rayonnement UV au produit d'étanchéité liquide à une longueur d'onde comprise entre 300 nm et 400 nm environ, et à une intensité d'irradiation d'au moins environ 1 W/cm2, de préférence, le durcissement du produit d'étanchéité liquide d'une phase liquide à une phase solide dans une période de temps inférieure à environ une minute, plus préférablement moins d'environ 1/2 minute, et encore plus préférablement moins d'environ 1/3 minute.
  8. Un procédé selon l'une des revendications 1 to 7, dans lequel le septum pénétrable (14) est suffisamment élastique pour se refermer après le retrait de l'élément de remplissage (72) du septum (14) et empêcher sensiblement le produit d'étanchéité de s'écouler à travers la région pénétrée du septum (14) et dans la chambre (16) du dispositif (12) ; et/ou le produit d'étanchéité liquide est suffisamment visqueux pour empêcher le produit d'étanchéité liquide de s'écouler à travers la région pénétrée du septum (14) et dans la chambre (16) du dispositif (12) avant que le produit d'étanchéité liquide ne devienne une phase solide.
  9. Un appareil (10) comprenant :
    un convoyeur (28) définissant un trajet pour transporter au moins un dispositif (12) le long du trajet, dans lequel chaque dispositif (12) comprend une partie pénétrable ou septum (14), pénétrable par un élément de remplissage ou d'injection (72) et une chambre hermétique (16) en communication fluidique avec le septum pénétrable (14) ; une station de décontamination (62) située sur le trajet du convoyeur (28) et configurée pour recevoir le dispositif (12) et décontaminer au moins une surface pénétrable du septum pénétrable (14) ;
    une station de remplissage (64) située sur le trajet du convoyeur (28) en aval de la station de décontamination (62) et comprenant au moins un élément de remplissage ou d'injection (72) qui est soit couplé soit connectable en communication fluidique avec une source de substance à remplir dans la chambre (16) du dispositif (12), soit connectable en communication fluidique avec une source de substance à remplir dans la chambre (16) du dispositif (12), dans lequel the l'élément de remplissage ou d'injection (72) et / ou le dispositif (12) est mobile par rapport à l'autre à l'intérieur de la station de remplissage (64) pour pénétrer le septum pénétrable (14) avec l'élément de remplissage ou d'injection (72),introduire la substance à travers l'élément de remplissage ou d'injection (72) et dans la chambre (16), et retirer l'élément de remplissage ou d'injection (72) du septum (14) ; et
    une station de rescellage (66) située sur le trajet du convoyeur (28) en aval de la station de remplissage (64) ;
    caractérisé en ce que la station de rescellage (66) comprend au moins un distributeur de produit d'étanchéité liquide (74) couplé ou connectable en communication fluidique avec une source de produit d'étanchéité liquide chauffé, pour appliquer un produit d'étanchéité liquide chauffé sur une région pénétrée du septum (14) et fermer hermétiquement la région pénétrée du septum (14).
  10. Un appareil (10) tel que défini dans la revendication 9, comprenant en outre une station de durcissement (68) située sur le trajet du convoyeur (28) en aval de la station de remplissage (64) et comprenant au moins une source de rayonnement ou d'énergie (75) pour appliquer un rayonnement au produit d'étanchéité liquide pour durcir le produit d'étanchéité liquide d'une phase liquide à une phase solide.
  11. Un appareil (10) tel que défini dans la revendication 9 ou 10, comprenant en outre au moins une source d'air stérile ou d'autre gaz couplée en communication fluidique avec les stations de décontamination, de remplissage, de rescellage et de durcissement (62, 64, 66, 68) et configurée pour introduire une surpression d'air stérile ou d'autre gaz dans chaque station (62, 64, 66, 68), et de préférence l'au moins une source d'air ou d'autre gaz stérile introduit la surpression d'air ou d'autre gaz stérile dans la station de remplissage (64) à une pression plus élevée que dans les stations de décontamination et de durcissement (62, 68) pour créer un gradient de pression positif entre la station de remplissage (64) et les stations de décontamination et de durcissement (62, 68).
  12. Un appareil (10) tel que défini dans l'une des revendications 10 à 11, dans lequel la station de durcissement (68) comprend au moins une source de rayonnement UV (70) configurée pour appliquer un rayonnement UV à une longueur d'onde comprise entre environ 300 nm et environ 400 nm, et à une intensité d'irradiation d'au moins environ 1 W/cm2.
  13. Un appareil (10) tel que défini dans l'une des revendications 9 à 12, dans lequel l'au moins un distributeur de produit d'étanchéité liquide (74) est mobile vers le septum (14) pour appliquer le produit d'étanchéité liquide, et peut être éloigné du septum (14) après l'application du produit d'étanchéité liquide.
  14. Un appareil (10) tel que défini dans l'une des revendications 9 à 13, comprenant en outre un châssis (18) et une pluralité de modules (22) montés sur le châssis (18), dans lequel chaque module (22) comprend une station de décontamination (62), une station de remplissage (64), une station de rescellage (66) et/ou une station de durcissement (68), de préférence chaque module (22) comprenant en outre une partie respective du convoyeur (28) et au moins l'un des modules (22) comprend une pluralité de stations (62, 64, 66, 68).
  15. Un appareil (10) tel que défini dans la revendication 14, dans lequel un premier module (22) comprend une pluralité de stations de décontamination (62), un deuxième module (22) situé en aval du premier module (22) sur le trajet du convoyeur (28) comprend une pluralité de stations de remplissage (64), un troisième module (22) situé en aval du module de remplissage (22) sur le trajet du convoyeur (28) comprend une pluralité de stations de rescellage (66).
  16. Un appareil (10) tel que défini dans les revendications 14 ou 15, dans lequel la pluralité de modules (22) sont montés en série les uns par rapport aux autres le long du trajet du convoyeur (28), chaque module (22) définit une entrée (24) à une extrémité du module de convoyeur respectif (30), et une sortie (26) à l'extrémité opposée du module de convoyeur respectif (30), et chacune d'une pluralité de sorties (26) définit les entrées (24) des modules adjacents (22).
  17. Un appareil (10) tel que défini dans l'une des revendications 9 à 16, comprenant en outre (i) un premier connecteur stérile (95) et un premier conduit de fluide (91) couplé entre le premier connecteur stérile (95) et l'élément de remplissage ou d'injection (72), et un deuxième connecteur stérile (97) et un deuxième conduit de fluide (93) couplé entre le deuxième connecteur stérile (97) et une source de substance à remplir, dans lequel le premier connecteur stérile (95) peut être connecté au deuxième connecteur stérile (97) pour former une connexion de fluide stérile fermée entre eux, et (ii) un troisième connecteur stérile (95) et un troisième conduit de fluide (91) couplé entre le troisième connecteur stérile (95) et le distributeur de produit d'étanchéité liquide (74), et un quatrième connecteur stérile (97) et un quatrième conduit de fluide (93) couplé entre le quatrième connecteur stérile (97) et une source de produit d'étanchéité liquide, dans lequel le troisième connecteur stérile (95) peut être connecté au quatrième connecteur stérile (97) pour former une connexion de fluide stérile fermée entre eux.
  18. Un appareil (10) tel que défini dans l'une des revendications 9 à 17, dans lequel la station de remplissage (64) comprend un support (78) comprenant une pluralité d'éléments de remplissage ou d'injection (72) espacés latéralement les uns par rapport aux autres et montés de manière fixe sur celui-ci, et une pluralité de capuchons (88), dans laquelle chaque capuchon (88) est relié de manière amovible à la monture (78) dans une position recouvrant un élément de remplissage ou d'injection respectif (72), et la monture (78) est relativement mobile vers le convoyeur (28) et à l'écart de celui-ci, et dans lequel le transporteur (28) comprend un dispositif de fixation de capuchon (36) comprenant une pluralité de surfaces de support de capuchon (92) pouvant s'engager avec des capuchons respectifs (88) lorsque le support (78) est déplacé relativement vers le transporteur (28) pour retenir de manière amovible les capuchons (88) sur celui-ci, et désengager les capuchons (88) du support (78) lorsque le support (78) est éloigné du convoyeur (28) pour exposer les éléments de remplissage ou d'injection (72) et les préparer à l'utilisation.
EP13775294.5A 2012-04-13 2013-04-12 Appareil de remplissage modulaire et procédé correspondant Not-in-force EP2836433B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP18198318.0A EP3456643A1 (fr) 2012-04-13 2013-04-12 Appareil et procédé de remplissage modulaire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261686867P 2012-04-13 2012-04-13
PCT/US2013/036296 WO2013155369A1 (fr) 2012-04-13 2013-04-12 Appareil de remplissage modulaire et procédé correspondant

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP18198318.0A Division EP3456643A1 (fr) 2012-04-13 2013-04-12 Appareil et procédé de remplissage modulaire

Publications (3)

Publication Number Publication Date
EP2836433A1 EP2836433A1 (fr) 2015-02-18
EP2836433A4 EP2836433A4 (fr) 2016-05-11
EP2836433B1 true EP2836433B1 (fr) 2018-10-03

Family

ID=49328183

Family Applications (2)

Application Number Title Priority Date Filing Date
EP13775294.5A Not-in-force EP2836433B1 (fr) 2012-04-13 2013-04-12 Appareil de remplissage modulaire et procédé correspondant
EP18198318.0A Withdrawn EP3456643A1 (fr) 2012-04-13 2013-04-12 Appareil et procédé de remplissage modulaire

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP18198318.0A Withdrawn EP3456643A1 (fr) 2012-04-13 2013-04-12 Appareil et procédé de remplissage modulaire

Country Status (14)

Country Link
US (2) US8966866B2 (fr)
EP (2) EP2836433B1 (fr)
JP (1) JP2015515421A (fr)
KR (2) KR20150013525A (fr)
CN (2) CN104507815B (fr)
AU (2) AU2013245750A1 (fr)
CA (1) CA2870307C (fr)
ES (1) ES2710920T3 (fr)
HK (2) HK1209088A1 (fr)
IN (1) IN2014DN08474A (fr)
MX (1) MX2014012377A (fr)
RU (1) RU2635382C2 (fr)
WO (1) WO2013155369A1 (fr)
ZA (1) ZA201407397B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2792051C (fr) * 2010-03-05 2017-02-28 Tosho, Inc. Dispositif de conditionnement separe de medicament
KR101107851B1 (ko) * 2010-11-12 2012-02-07 삼성엘이디 주식회사 형광체 자동 배합기 및 형광체 자동 배합 방법
JP5791459B2 (ja) * 2011-10-17 2015-10-07 日立造船株式会社 電子線殺菌設備の遮蔽構造
MX2014012377A (es) * 2012-04-13 2015-05-11 Py Inst Llc Dr Aparato de llenado modular y metodo.
EP2754614B1 (fr) * 2013-01-14 2015-06-24 Edwin Kohl Installation et procédé destinés au remplissage pour une personne de blisters avec des médicaments
US9415885B2 (en) 2013-03-15 2016-08-16 Dr. Py Institute Llc Device with sliding stopper and related method
DE102014000132A1 (de) 2014-01-13 2015-07-16 Marco Bergmann Verfahren und Vorrichtung zum Anordnen mehrerer Lebensmittel in wenigstens einem Unterteil einer Verpackung
ES2551809B1 (es) 2014-05-21 2016-05-17 Kiro Robotics Sl Máquina de preparación de sustancias de aplicación intravenosa
DE102016111357A1 (de) * 2016-06-10 2017-12-14 Weber Maschinenbau Gmbh Breidenbach Vorrichtung zum Transport von Objekten
IT201600074164A1 (it) * 2016-07-15 2018-01-15 Nuova Ompi Srl Metodo di manipolazione di contenitori primari per uso farmaceutico trasportati lungo una linea automatica di trattamento operante in ambiente controllato
US10643875B2 (en) 2016-09-09 2020-05-05 The Procter & Gamble Company System and method for simultaneously filling containers with different fluent compositions
EP3510459A2 (fr) * 2016-09-09 2019-07-17 The Procter and Gamble Company Système et procédé pour l'acheminement indépendant de véhicules chargés de conteneurs pour créer différents produits finis
CA3035537C (fr) 2016-09-09 2021-07-20 The Procter & Gamble Company Systeme et procede de remplissage simultane de recipients de formes et/ou de tailles differentes
US10558201B2 (en) 2016-09-09 2020-02-11 The Procter & Gamble Company System and method for producing products based upon demand
EP3510457A1 (fr) 2016-09-09 2019-07-17 The Procter and Gamble Company Procédés de production simultanée de produits différents sur une seule ligne de production
EP4194378A1 (fr) * 2016-09-09 2023-06-14 The Procter & Gamble Company Système et procédé pour acheminer indépendamment des véhicules et distribuer des récipients et des fermetures à des stations d'exploitation unitaires
CA3035540C (fr) 2016-09-09 2021-04-06 The Procter & Gamble Company Systeme de voie pour la creation de produits finis
KR20200091919A (ko) * 2017-12-11 2020-07-31 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 모듈식 무균 생산 시스템
IT201800004068A1 (it) * 2018-03-29 2019-09-29 Marchesini Group Spa Macchina per il riempimento e la chiusura di contenitori farmaceutici, quali siringhe, flaconi e simili
CA3096669A1 (fr) 2018-04-13 2019-10-17 Nqv8 Llc Desinfection d'unites alimentaires prequantifiees pretes a l'emballage
GB201905196D0 (en) * 2019-04-12 2019-05-29 Randox Laboratories Ltd Sterilisation assembly
DE102019130364A1 (de) * 2019-11-11 2021-05-12 Khs Gmbh Lineare Füllmaschine zum Befüllen von Behältern mit Füllgut
US20210171231A1 (en) * 2019-12-09 2021-06-10 Revessel Inc Robotic automated filling and capping system for vape oil cartridges
DE102020122569A1 (de) 2020-08-28 2022-03-03 Leibinger Gmbh Vorrichtung und Verfahren zum Behandeln von Behältern
JP2024501792A (ja) * 2020-12-28 2024-01-16 バクスター・インターナショナル・インコーポレイテッド 滅菌溶液充填コンテナを生産するための方法およびシステム
NL2027499B1 (en) * 2020-12-29 2022-07-21 Nutcracker Therapeutics Inc Filling systems and related container assemblies and methods
CN113697747B (zh) * 2021-09-17 2023-01-03 苏州凌耀制药设备有限公司 一种液态药剂灌装方法及其设备
US11851221B2 (en) * 2022-04-21 2023-12-26 Curium Us Llc Systems and methods for producing a radioactive drug product using a dispensing unit
DE102022117975A1 (de) * 2022-07-19 2024-01-25 Khs Gmbh Dosenverschließanordnung, Dosenfüllanlage sowie Verfahren zum Verschließen von Dosen
CN115763308B (zh) * 2022-11-09 2023-06-23 珠海映讯芯光科技有限公司 多路单项充气设备、控制方法及存储介质

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036785A1 (fr) * 1996-04-02 1997-10-09 Weston Medical Limited Procede pour remplir une capsule avec un medicament et produit resultant

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637102A (en) * 1970-05-25 1972-01-25 Continental Can Co Closures for aseptic filled containers
US4045939A (en) * 1976-01-23 1977-09-06 Papeteries De Belgique Process for the production of a packaging receiving a sterile liquid
US4409775A (en) * 1977-08-22 1983-10-18 The Mead Corporation Apparatus for the aseptic packing of high acid food
NZ195962A (en) * 1980-01-16 1984-11-09 Metal Box Co Ltd Vacuum packing a product in a rigid container so as to leave no headspace
US4417607A (en) * 1981-06-29 1983-11-29 Scholle Corporation Apparatus and method for aseptically filling flexible containers
US5195298A (en) * 1991-01-15 1993-03-23 Campbell Soup Company Container filling and sealing system
AU1932895A (en) * 1994-03-02 1995-09-18 Tl Systems Corporation Sterile vial filling apparatus
FR2719018B1 (fr) 1994-04-26 1996-07-12 Py Daniel C Procédé pour remplir dans des conditions aseptiques un récipient obturé.
US5829228A (en) * 1996-04-25 1998-11-03 Tetra Laval Holdings & Finance, Sa Method and apparatus for forming the top of a container
DE19642987A1 (de) * 1996-10-18 1998-04-23 Tetra Laval Holdings & Finance Verfahren und Vorrichtung zum Sterilisieren und Befüllen von Verpackungsbehältern
US5884457A (en) * 1997-02-05 1999-03-23 Smithkline Beecham Corporation Method and apparatus for automatically producing a plurality of sterile liquid filled delivery devices
US6050435A (en) * 1997-03-28 2000-04-18 Rexam Plastics, Inc. Closure with integral self-sealing silicone valve and method for making same
US6164044A (en) * 1998-03-13 2000-12-26 Becton Dickinson And Company Method and apparatus for assembling and packaging medical devices
US6120730A (en) * 1998-06-26 2000-09-19 Tetra Laval Holdings & Finance, Sa Heat and hydrogen peroxide gas sterilization of container
US6604561B2 (en) 2000-02-11 2003-08-12 Medical Instill Technologies, Inc. Medicament vial having a heat-sealable cap, and apparatus and method for filling the vial
US7669390B2 (en) * 2004-03-08 2010-03-02 Medical Instill Technologies, Inc. Method for molding and assembling containers with stoppers and filling same
US7707807B2 (en) 2004-03-08 2010-05-04 Medical Instill Technologies, Inc. Apparatus for molding and assembling containers with stoppers and filling same
US6740345B2 (en) * 2000-12-22 2004-05-25 Edward Zhihua Cai Beverage making cartridge
US6536648B2 (en) * 2001-03-20 2003-03-25 Avery Dennison Corporation System for dispensing plastic fasteners
JP2005511444A (ja) * 2001-12-14 2005-04-28 ストーク フード アンド デアリー システムズ ベー．フェー． 指向された気体供給を有するハウジングを備えた充填デバイス
US20060100408A1 (en) 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
JP4782417B2 (ja) 2002-06-19 2011-09-28 メディカル・インスティル・テクノロジーズ・インコーポレイテッド 電子ビームチャンバ内ニードル充填ステーション付き無菌充填マシン
US20040022222A1 (en) * 2002-07-31 2004-02-05 Allister Clisham Wireless metropolitan area network system and method
AU2003299041B2 (en) 2002-09-03 2008-06-05 Medical Instill Technologies, Inc. Sealed containers and methods of making and filling same
MXPA05008098A (es) 2003-01-28 2006-02-08 Medical Instill Tech Inc Frasco de medicamento que tiene una tapa que se puede sellar con calor y aparato y metodo de llenado del frasco.
JP2006518317A (ja) * 2003-02-19 2006-08-10 ザ・コカ−コーラ・カンパニー 液状製品の容器への無菌充填のためのシステムと方法
US7628184B2 (en) 2003-11-07 2009-12-08 Medical Instill Technologies, Inc. Adjustable needle filling and laser sealing apparatus and method
US7096896B2 (en) * 2004-03-05 2006-08-29 Medical Instill Technologies, Inc. Apparatus and method for needle filling and laser resealing
US7543708B2 (en) 2004-08-23 2009-06-09 United States Gypsum Company Plastic bag for fine powders
ITBO20050010A1 (it) * 2005-01-12 2006-07-13 Ima Spa Impianto compatto per il confezionamento in ambiente sterile di prodotti liquidi iniettabili in contenitori
CN104477496A (zh) 2005-01-25 2015-04-01 因斯蒂尔医学技术有限公司 用于存储含脂流体产品的容器及方法
WO2006099507A2 (fr) * 2005-03-11 2006-09-21 Medical Instill Technologies, Inc. Appareil et methode de demoulage sterile
US7906134B2 (en) * 2005-12-21 2011-03-15 Abbott Laboratories Room temperature-curable polymers
WO2007120719A2 (fr) * 2006-04-10 2007-10-25 Medical Instill Technologies, Inc. Conteneur prêt à boire avec tétine, partie pouvant être pénétrée par une aiguille et libérée au laser, et procédé associé
US7750333B2 (en) * 2006-06-28 2010-07-06 Intel Corporation Bit-erasing architecture for seek-scan probe (SSP) memory storage
CA2702135C (fr) * 2007-10-04 2013-08-20 Daniel Py Appareil et procede de formulation et de remplissage aseptique de produits liquides
KR101581651B1 (ko) * 2008-03-31 2015-12-30 코닝 인코포레이티드 시일된 유리 조립체를 패키징하기 위한 베젤
DE102009003025A1 (de) * 2009-05-12 2010-11-18 Ball Packaging Europe Gmbh Verfahren zum Befüllen von Lebenmittelbehältern
KR101560582B1 (ko) * 2009-10-09 2015-10-16 다니엘 파이 공동 성형된 클로져, 1 방향 밸브 및 체적 가변형 저장 챔버를 가진 장치, 및 관련 방법
US20120021107A1 (en) * 2010-07-23 2012-01-26 Robert Andrew Knowlton Method and apparatus for processing produce
EP2420450A1 (fr) * 2010-08-17 2012-02-22 Aseptic Technologies Appareil de remplissage d'un produit dans un conteneur dans des conditions aseptiques
BR112013009841A2 (pt) * 2010-10-22 2018-05-02 Py Daniel conector de bolsa e método relacionado
CN108619536A (zh) * 2011-06-21 2018-10-09 丹尼尔·皮 流体灭菌剂注射灭菌装置和方法
DE102011119657B4 (de) * 2011-11-29 2015-03-12 Gerhard Schubert Gmbh Verpackungsmaschine für keimfreies Abpacken
MX2014012377A (es) * 2012-04-13 2015-05-11 Py Inst Llc Dr Aparato de llenado modular y metodo.
AU2014233167B2 (en) * 2013-03-15 2017-03-16 Dr. Py Institute, Llc Controlled non-classified filling device and method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036785A1 (fr) * 1996-04-02 1997-10-09 Weston Medical Limited Procede pour remplir une capsule avec un medicament et produit resultant

Also Published As

Publication number Publication date
IN2014DN08474A (fr) 2015-05-08
CN104507815B (zh) 2017-06-09
KR20170138590A (ko) 2017-12-15
EP2836433A4 (fr) 2016-05-11
WO2013155369A1 (fr) 2013-10-17
US10273025B2 (en) 2019-04-30
AU2016210672A1 (en) 2016-08-25
CN107253545A (zh) 2017-10-17
AU2013245750A1 (en) 2014-11-06
CA2870307C (fr) 2017-07-25
US20150175281A1 (en) 2015-06-25
EP2836433A1 (fr) 2015-02-18
ES2710920T3 (es) 2019-04-29
US8966866B2 (en) 2015-03-03
MX2014012377A (es) 2015-05-11
KR20150013525A (ko) 2015-02-05
CA2870307A1 (fr) 2013-10-17
HK1245740A1 (zh) 2018-08-31
RU2635382C2 (ru) 2017-11-13
ZA201407397B (en) 2016-09-28
CN104507815A (zh) 2015-04-08
US20130283733A1 (en) 2013-10-31
EP3456643A1 (fr) 2019-03-20
JP2015515421A (ja) 2015-05-28
HK1209088A1 (en) 2016-03-24
RU2014145529A (ru) 2016-06-10

Similar Documents

Publication Publication Date Title
EP2836433B1 (fr) Appareil de remplissage modulaire et procédé correspondant
RU2626198C2 (ru) Регулируемое неклассифицированное наполняющее устройство и способ
US6929040B2 (en) Sterile filling machine having needle filling station within e-beam chamber
US8182744B2 (en) Ultraviolet sanitization in pharmacy environments
CA2676695C (fr) Desinfection par ultraviolets dans des environnements pharmaceutiques
JP2015515421A5 (fr)
US7874129B2 (en) Sterile de-molding apparatus and method
WO2015124358A1 (fr) Machine de stérilisation et procédé de stérilisation de récipients d'emballage

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20141028

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 2/00 20060101ALI20151109BHEP

Ipc: B65B 55/02 20060101AFI20151109BHEP

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20160408

RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 2/00 20060101ALI20160404BHEP

Ipc: B65B 55/02 20060101AFI20160404BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20170120

RIC1 Information provided on ipc code assigned before grant

Ipc: B65B 55/08 20060101ALI20180124BHEP

Ipc: B65B 3/00 20060101ALI20180124BHEP

Ipc: B65B 39/00 20060101ALN20180124BHEP

Ipc: B65B 7/16 20060101ALN20180124BHEP

Ipc: B65B 61/00 20060101ALI20180124BHEP

Ipc: B65B 51/02 20060101AFI20180124BHEP

Ipc: B65B 55/10 20060101ALI20180124BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602013044534

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: B65B0055020000

Ipc: B65B0051020000

INTG Intention to grant announced

Effective date: 20180309

RIC1 Information provided on ipc code assigned before grant

Ipc: B65B 51/02 20060101AFI20180226BHEP

Ipc: B65B 7/16 20060101ALN20180226BHEP

Ipc: B65B 55/08 20060101ALI20180226BHEP

Ipc: B65B 55/10 20060101ALI20180226BHEP

Ipc: B65B 61/00 20060101ALI20180226BHEP

Ipc: B65B 39/00 20060101ALN20180226BHEP

Ipc: B65B 3/00 20060101ALI20180226BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTC Intention to grant announced (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: B65B 55/10 20060101ALI20180329BHEP

Ipc: B65B 51/02 20060101AFI20180329BHEP

Ipc: B65B 3/00 20060101ALI20180329BHEP

Ipc: B65B 61/00 20060101ALI20180329BHEP

Ipc: B65B 7/16 20060101ALN20180329BHEP

Ipc: B65B 55/08 20060101ALI20180329BHEP

Ipc: B65B 39/00 20060101ALN20180329BHEP

INTG Intention to grant announced

Effective date: 20180420

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1048334

Country of ref document: AT

Kind code of ref document: T

Effective date: 20181015

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602013044534

Country of ref document: DE

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1048334

Country of ref document: AT

Kind code of ref document: T

Effective date: 20181003

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2710920

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20190429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190103

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190203

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190103

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190104

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190203

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602013044534

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

26N No opposition filed

Effective date: 20190704

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20190430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190412

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190412

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20130412

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20211022

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20211022

Year of fee payment: 9

Ref country code: DE

Payment date: 20211101

Year of fee payment: 9

Ref country code: ES

Payment date: 20211102

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20211022

Year of fee payment: 9

Ref country code: FR

Payment date: 20211025

Year of fee payment: 9

Ref country code: CH

Payment date: 20211022

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181003

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602013044534

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20220501

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20220412

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220501

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220430

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220412

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220430

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20221103

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220412

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20230627

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220413